|
Market Closed -
Nasdaq
16:00:00 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 12.17 USD | +3.93% |
|
+2.53% | +58.05% |
| 08-12 | B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating | MT |
| 08-11 | Fennec Pharmaceuticals at Multi-Year High After Swing to Q2 Earnings Beat | MT |
| Market Cap | 411M 352M 331M 302M 570M 39.17B 573M 3.91B 1.52B 19.76B 1.54B 1.51B 65.44B | P/E 2026 * |
37.7x | P/E 2027 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 411M 352M 331M 302M 570M 39.17B 573M 3.91B 1.52B 19.76B 1.54B 1.51B 65.44B | EV / Sales 2026 * |
5.63x | EV / Sales 2027 * | 3.98x |
| Free-Float |
80.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fennec Pharmaceuticals Inc.
| 1 day | +3.93% | ||
| 1 week | +2.53% | ||
| Current month | +27.17% | ||
| 1 month | +21.82% | ||
| 3 months | +22.56% | ||
| 6 months | +37.20% | ||
| Current year | +58.05% |
| 1 week | 10.88 | 12.28 | |
| 1 month | 9.4 | 13.25 | |
| Current year | 5.65 | 13.25 | |
| 1 year | 5.65 | 13.25 | |
| 3 years | 3.96 | 13.25 | |
| 5 years | 3.82 | 13.25 | |
| 10 years | 1.64 | 14.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeffrey Hackman
CEO | Chief Executive Officer | 64 | 2024-08-15 |
Robert Andrade
DFI | Director of Finance/CFO | 51 | 2010-01-05 |
Pierre Sayad
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 72 | 2011-08-24 |
Khalid Islam
CHM | Chairman | 69 | 2015-12-08 |
Marco Brughera
BRD | Director/Board Member | 70 | 2016-08-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/3/26 | Buy | Chief Technology Officer | 168 | 0.0005% | ||
| 8/3/26 | Buy | Executive/Senior Manager | 168 | 0.0005% | ||
| 8/3/26 | Sell | -10,000 | 0.0288% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.93% | +2.53% | +40.69% | +48.41% | 411M | ||
| -3.59% | -2.96% | +71.06% | +114.83% | 1,100B | ||
| -1.15% | -0.41% | +51.34% | +62.41% | 658B | ||
| -1.09% | +1.54% | +26.67% | +79.22% | 470B | ||
| -1.47% | +2.05% | +41.71% | +42.09% | 372B | ||
| -0.90% | +1.29% | +25.62% | +41.75% | 304B | ||
| -1.94% | +1.53% | +3.05% | +13.24% | 264B | ||
| -0.43% | +3.54% | +52.65% | +71.75% | 239B | ||
| -0.93% | +2.90% | -16.98% | -52.28% | 213B | ||
| -0.46% | +3.24% | +29.73% | +92.67% | 184B | ||
| Average | -0.76% | +2.57% | +32.55% | +51.41% | 380.33B | |
| Weighted average by Cap. | -1.77% | +2.21% | +42.86% | +68.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 72.9M 62.57M 58.73M 53.64M 101M 6.95B 102M 695M 269M 3.51B 274M 268M 11.62B | 103M 88.54M 83.1M 75.9M 143M 9.84B 144M 983M 381M 4.96B 387M 379M 16.44B |
| Net income | 11.25M 9.65M 9.06M 8.27M 15.62M 1.07B 15.69M 107M 41.55M 541M 42.23M 41.31M 1.79B | 35.24M 30.24M 28.39M 25.93M 48.93M 3.36B 49.16M 336M 130M 1.7B 132M 129M 5.62B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-26 | US$12.17 | +3.93% | 250,551 |
| 26-08-25 | US$11.71 | +2.72% | 198,353 |
| 26-08-24 | US$11.40 | +0.97% | 218,904 |
| 26-08-21 | US$11.29 | -0.53% | 210,738 |
| 26-08-20 | US$11.35 | -4.38% | 246,211 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FENC Stock
Select your edition
All financial news and data tailored to specific country editions

















